Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.6632 per EA under NDC 00378224577. Its NADAC has been published 403 times since Nov 8, 2017.
Strength
100 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378224577
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA204644On Market Since
9/28/2017
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 403 times since Nov 8, 2017, and over the history we have for it it has declined 98.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6632 per EA |
|---|---|
| All-time high | $46.7871 (Jan 10, 2018) |
| All-time low | $0.3890 (May 22, 2024) |
| 52-week high | $0.9761 |
| 52-week low | $0.6632 |
| Median price | $0.9580 |
| Average price | $6.2992 |
| Largest weekly change | -82.3% (Oct 17, 2018) |
| Weeks tracked | 403 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.6632 per EA (NDC 00378224577), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 98.6%. It has been tracked across 403 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since Nov 8, 2017, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.3890 (May 22, 2024) to a high of $46.7871 (Jan 10, 2018), with a median of $0.9580 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 100 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 00378224577) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification